Tolvaptan-Octreotide LAR Combination in ADPKD - Test2 - elhamkhani - TriplyDB

Tolvaptan-Octreotide LAR Combination in ADPKD

Tolvaptan-Octreotide LAR Combination in ADPKD

http://www.wikidata.org/entity/Q62811791

about

Tolvaptan-Octreotide LAR Combination in ADPKD

http://www.wikidata.org/entity/Q62811791

description

clinical trial

@en

klinisch onderzoek

@nl

name

Tolvaptan-Octreotide LAR Combination in ADPKD

@en

type

label

Tolvaptan-Octreotide LAR Combination in ADPKD

@en

prefLabel

Tolvaptan-Octreotide LAR Combination in ADPKD

@en

P1132

Q62811791-513D983D-CF6D-4E8F-A03E-0D7F791E2A9D

P1476

Q62811791-35296E33-3B6F-4668-9DFE-1AA56DCF6B79

P17

Q62811791-F09A1580-2B0D-4AB7-8976-61B422843FE2

P1813

Q62811791-40005225-9BF2-497E-B86E-D13C26CA0675

P2899

Q62811791-DC5EC374-19D6-46A6-81B7-2E43E67BCAB0

P3098

Q62811791-AF630466-9422-479B-820C-ADCDA8452E80

P31

Q62811791-6E0B4EA2-4FEC-460D-802E-BF066161911E

P4844

Q62811791-19904B16-8863-488D-9E09-D0C3387E189D

P580

Q62811791-39F49D83-8614-4B77-BC21-9EE03DF8A471

P582

Q62811791-DFD67A1C-9790-417D-9885-BDFEEE908584

P6099

Q62811791-D493D8AE-433B-4053-A339-2AD7BB278325

P8005

Q62811791-817038F9-C466-43DA-985B-0EE35FA75551

P859

Q62811791-ECF6D532-85A1-4AAB-A2F0-25F47A09A341

P1132

20

http://www.w3.org/2001/XMLSchema#decimal

P1476

A Pilot, Phase II Study With a ...... ey Function or Hyperfiltration

@en

P17

P1813

TOOL

@en

P2899

18

http://www.w3.org/2001/XMLSchema#decimal

P3098

NCT03541447

http://www.w3.org/2001/XMLSchema#string

P31

P4844

P580

2018-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P582

2020-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6099

phase II clinical trial

P8005

P859

Mario Negri Institute for Pharmacological Research